|
Market Closed -
Nasdaq
16:00:00 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 39.66 USD | -1.95% |
|
-9.08% | +30.72% |
| 08-05 | Rapport Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-28 | William Blair Initiates Rapport Therapeutics at Outperform | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RAPP | Delayed | |
CBOE
| RAPP | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 46.09 | 52.5 | 48.77 |
| Spread/Res. | -13.95% | -24.46% | -18.68% |
| Spread/Supp. | +2.83% | +2.83% | +17.03% |
| Support | 38.57 | 38.57 | 33.89 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RAPP Stock
- Charts Rapport Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
